Results 1 to 10 of about 39,256 (202)
Neuromodulation in Drug Resistant Epilepsy [PDF]
Aging and disease, 2021 Epilepsy affects approximately 70 million people worldwide, and it is a significant contributor to the global burden of neurological disorders. Despite the advent of new AEDs, drug resistant-epilepsy continues to affect 30-40% of PWE. Once identified as having drug-resistant epilepsy, these patients should be referred to a comprehensive epilepsy center
Naymee Vélez-Ruiz
exaly +4 more sources
Surgery for drug-resistant focal epilepsy
Annals of Indian Academy of Neurology, 2014 During the colloquium on drug-resistant epilepsy (DRE) at National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore on August 16-18, 2013, a number of presentations were made on the surgically remediable lesional epilepsy syndromes ...
Malla Bhaskara Rao +6 more
doaj +4 more sources
Drug-Resistant Epilepsy and Surgery [PDF]
Current Neuropharmacology, 2017 Epilepsy is a chronic brain disease that is caused by various factors and characterized by recurrent, episodic and temporary central nervous system dysfunction which results due to excessive discharge of brain neurons. In the past decades, despite the continuous development of antiepileptic drugs, there are still many patients with epilepsy progressing
Jiyao Sheng, Shui Liu, Bingjin Li
exaly +3 more sources
Epilepsia Open, 2022 More than one‐third of people with epilepsy develop drug‐resistant epilepsy (DRE). Different hypotheses have been proposed to explain the origin of DRE. Accumulating evidence suggests the contribution of neuroinflammation, modifications in the integrity ...
Patricia Campos‐Bedolla +2 more
doaj +3 more sources
Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan [PDF]
Future Science OAIntroduction The prevalence of drug-resistant epilepsy (DRE) among epilepsy patients has not decreased despite better diagnostic methods and treatment options because it affects approximately one-third of all epilepsy patients.
Gulzira Baimakhanova +11 more
doaj +2 more sources
Epidemiology of drug resistant epilepsy in adults
Бюллетень сибирской медицины, 2018 This review examines the epidemiology of drug resistant epilepsy in adults in Russia and abroad. References were taken from Russian and foreign databases for the period from 2010–2017. Only full-text publications (66) were included in this review.
E. A. Narodova +5 more
doaj +2 more sources
Pathogenesis of drug resistant epilepsy
Эпилепсия и пароксизмальные состояния, 2019 Pharmacotherapy is the first-line treatment modality for epilepsy. However, in 20-40% of patients, epilepsy is resistant to pharmacotherapy. These numbers have not changed for decades despite the development and use of antiepileptic drugs with novel ...
S. M. Malyshev +3 more
doaj +3 more sources
Archives of Epilepsy, 2020 Objectives:This retrospective study aimed to overview the efficacy and side effects of clobazam in patients with drug-resistant epilepsy who were followed in a tertiary epilepsy center.Methods:The patients who had been started clobazam as add-on therapy ...
Nermin Görkem ŞİRİN +2 more
doaj +2 more sources
Responsive neurostimulation for treatment of pediatric drug-resistant epilepsy [PDF]
Epilepsy and Behavior Case Reports, 2018 Responsive neurostimulation for epilepsy involves an implanted device that delivers direct electrical brain stimulation in response to detection of incipient seizures.
Nilika S. Singhal +6 more
doaj +2 more sources
Survey on Antiepileptic Drug Therapy in Patients with Drug Resistant Epilepsy [PDF]
, 2021 Background and purpose: Individualized anti-epileptic drug (AED) selection in patient with epilepsy is crucial. However, there is no unified opinion in treating patients with drug resistant epilepsy (DRE).
주민경
core +1 more source